UK Companies House feature
CONTURA INTERNATIONAL LIMITED
Profile
- Company number
- 13119454
- Status
- Active
- Incorporation
- 2021-01-07
- Last accounts made up
- 2024-12-31
- Account category
- GROUP
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated (group)
- Auditor
- MHA
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on the foregoing these financial statements have been prepared on a going concern basis.”
Subsidiaries
- Contura A/S · 100% held · Denmark · Danish holding company
- Contura International A/S · 100% held · Denmark · Medical device sales and licensing
- Contura Properties A/S · 100% held · Denmark · Property company
- Contura Sydmarken 29 A/S · 100% held · Denmark · Property company
Significant events
- “On 11th July 2024 the Business overdraft facility was increased to DKK 67,500,000 (equivalent to £7,644,827).”
- “On 5th February 2024, the Company issued a tranche of 2,000,000 Preference Shares of £1.00 each at par in respect of a Subscription Agreement for up to 18,000,000 Preference Shares.”
- “The Group is expanding its production facility at Sydmarken 23, 2860 Söborg, Denmark to substantially increase its capacity to accommodate anticipated increases in product demand.”
- “Contura Sydmarken 29 A/S was incorporated in Denmark on 15 February 2024 as a 100% owned subsidiary of the Company. Contura Sydmarken 29 A/S acquired the land and buildings at Sydmarken 29, DK-2860 Soeborg on 1 March 2024 for DKK 50,000,000 (equivalent to £5,662,845).”
- “Subsequent to the year end, on 31 January 2025, the seller vacated the property. On vacation of the property, DKK 10,000,000 of the loan was repaid by Contura Sydmarken 29 A/S to the seller, thereby reducing the loan to DKK 35,000,000.”
- “Subsequent to the year end, on 20th February 2025, the Business overdraft facility from Danske Bank has been increased to DKK 104,500,000 (equivalent to £11,835,324).”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
6 active · 0 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BANKS, Patrick John | Secretary | 2021-01-07 | — | — |
| BANKS, Patrick John | Director | 2021-01-07 | Aug 1962 | British |
| FRASER-PYE, Graham Julian | Director | 2021-01-07 | Mar 1968 | British |
| JACOBSON, Ian | Director | 2021-01-07 | Mar 1960 | Canadian |
| PODOLSKY, Craig | Director | 2021-01-07 | Feb 1981 | Canadian |
| TAILOR, Rakesh Chhaganlal | Director | 2021-01-07 | Mar 1974 | British |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Juno Pharmaceuticals Lp | Corporate entity | Shares 50–75% | 2021-03-01 | Active |
| Contura Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2021-01-07 | Ceased 2021-03-01 |
Filing timeline
Last 20 of 26 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-03-13 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2026-01-08 | AA | accounts | accounts with accounts type group |
| 2025-11-28 | SH01 | capital | capital allotment shares |
| 2025-01-28 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-01-06 | AA | accounts | accounts with accounts type group |
| 2024-09-09 | SH01 | capital | capital allotment shares |
| 2024-02-09 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-01-10 | AA | accounts | accounts with accounts type group |
| 2023-07-21 | SH01 | capital | capital allotment shares |
| 2023-03-30 | SH01 | capital | capital allotment shares |
| 2023-03-30 | SH01 | capital | capital allotment shares |
| 2023-01-30 | CS01 | confirmation-statement | confirmation statement with updates |
| 2023-01-08 | AA | accounts | accounts with accounts type group |
| 2022-12-01 | SH01 | capital | capital allotment shares |
| 2022-11-14 | MA | incorporation | memorandum articles |
| 2022-11-14 | RESOLUTIONS | resolution | resolution |
| 2022-04-28 | MA | incorporation | memorandum articles |
| 2022-04-27 | RESOLUTIONS | resolution | resolution |
| 2022-04-26 | SH01 | capital | capital allotment shares |
| 2022-02-15 | CS01 | confirmation-statement | confirmation statement with updates |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.